BIBW 2992 (Afatinib) With or Without Daily Temozolomide in the Treatment of Patients With Recurrent Malignant Glioma
Clinical trial NCT00727506 · COMPLETED
Trial details
- NCT number
- NCT00727506
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-14
- Primary completion
- 2011-05-12
- Enrollment
- 151
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.